FN2 Earnings Intelligence
Molina Healthcare, Inc. financials
Molina Healthcare, Inc. (MOH) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $4,438 | $4,006 | $4,848 | $4,662 | $4,248 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $27,771 | $31,974 | $34,072 | $40,650 | $45,426 | $44,511.3 | $48,202.7 |
| % Growth | 43.0% | 15.1% | 6.6% | 19.3% | 11.7% | -2.0% | 8.3% |
| Gross Profit | $3,165 | $3,719 | $3,869 | $4,199 | $3,564 | - | - |
| % Margin | 11.4% | 11.6% | 11.4% | 10.3% | 7.8% | - | - |
| EBITDA | $1,151 | $1,349 | $1,744 | $1,893 | $976 | - | - |
| % Margin | 4.1% | 4.2% | 5.1% | 4.7% | 2.1% | - | - |
| Net Income | $659 | $792 | $1,091 | $1,179 | $472 | - | - |
| % Margin | 2.4% | 2.5% | 3.2% | 2.9% | 1.0% | - | - |
| Diluted EPS | $11.25 | $13.55 | $18.77 | $20.42 | $8.92 | $5.23 | $9.76 |
| % Growth | 0.2% | 20.4% | 38.5% | 8.8% | -56.3% | -41.3% | 86.5% |
| Operating Cash Flow | $2,119 | $773 | $1,662 | $644 | -$535 | - | - |
| CapEx | $77 | $91 | $84 | $100 | $101 | - | - |
| Free Cash Flow | $2,042 | $682 | $1,578 | $544 | -$636 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $27,771 | $31,974 | $34,072 | $40,650 | $45,426 | $44,511.3 | $48,202.7 |
| Gross Profit | $3,165 | $3,719 | $3,869 | $4,199 | $3,564 | - | - |
| EBITDA | $1,151 | $1,349 | $1,744 | $1,893 | $976 | - | - |
| Net Income | $659 | $792 | $1,091 | $1,179 | $472 | - | - |
| Diluted EPS | $11.25 | $13.55 | $18.77 | $20.42 | $8.92 | $5.23 | $9.76 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $4,438 | $4,006 | $4,848 | $4,662 | $4,248 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $2,173 | $2,176 | $2,180 | $2,923 | $3,766 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $2,119 | $773 | $1,662 | $644 | -$535 |
| Capital Expenditure | $77 | $91 | $84 | $100 | $101 |
| Free Cash Flow | $2,042 | $682 | $1,578 | $544 | -$636 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 43.0% | 15.1% | 6.6% | 19.3% | 11.7% |
| Gross Margin | 11.4% | 11.6% | 11.4% | 10.3% | 7.8% |
| EBITDA Margin | 4.1% | 4.2% | 5.1% | 4.7% | 2.1% |
| Net Margin | 2.4% | 2.5% | 3.2% | 2.9% | 1.0% |
| FCF Margin | 7.4% | 2.1% | 4.6% | 1.3% | -1.4% |
| Diluted EPS Growth | 0.2% | 20.4% | 38.5% | 8.8% | -56.3% |